SCHEMBL5838995

SCHEMBL5838995

Cc1cn(-c2ccc(Cl)c(C(=O)NC(O)C3CCCCC3)c2)c(=O)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 8/20 0.46
CNR1 P21554 3/20 0.37
CNR2 P34972 3/20 0.37
MAPT P10636 2/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HSP90AA1 P07900 1/20 0.36
G6PD P11413 1/20 0.36
PKM P14618 1/20 0.36
CCR6 P51684 1/20 0.36
MCL1 Q07820 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
THRB P10828 1/20 0.36
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5838675 1.00 P2RX7 (0.46) P2RX7CNR1CNR2MAPTTP53
SCHEMBL5837478 0.86 HSD17B1 (0.51) P2RX7CNR1CNR2NPC1RAB9A
SCHEMBL6256315 0.86 HSD17B1 (0.43) P2RX7CNR1CNR2
SCHEMBL5957075 0.82 P2RX7 (0.45) P2RX7CNR1CNR2HPGDSMN1; SMN2
SCHEMBL5838979 0.82 P2RX7 (0.45) P2RX7CNR1CNR2HPGDSMN1; SMN2
SCHEMBL5839014 0.82 P2RX7 (0.49) P2RX7CNR1CNR2
SCHEMBL5838143 0.82 P2RX7 (0.49) P2RX7CNR1CNR2
SCHEMBL1412889 0.82 P2RX7 (0.69) P2RX7THRB
SCHEMBL1412974 0.82 P2RX7 (0.69) P2RX7THRB
SCHEMBL5838488 0.81 P2RX7 (0.39) P2RX7CNR1CNR2MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060217430-A1 Benzamide inhibitors of the P2X7 receptor DOMBROSKI MARK A 2006-09-28 US disclosed
US-7071223-B1 Benzamide inhibitors of the P2X7 receptor PFIZER, INC. (US) 2006-07-04 US disclosed
EP-1581507-A1 BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR Pfizer Products Inc. (US) 2005-10-05 EP disclosed
WO-2004058731-A1 BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR PFIZER PRODUCTS INC. (US) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217430-A1 Benzamide inhibitors of the P2X7 receptor IL1R1, P2RY1, P2RX1 P2RX7 7/4885CNR1 62/4885CNR2 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.